GGrantIndex
Sort

4,870 grants matching glp 1

Non-invasive beta-cell imaging using a Ga-68-labeled glucagone-like peptide-1 ana

$142,737
Gotthardt Martin · Radboud University Nijmegen Med Ctr · R01 · FY2008 · AG

Vector Core

$142,616
Julie Johnston · University Of Pennsylvania · P01 · FY2010 · HD

Pre-Clinical Vector Production Core

$142,230
William F. Goins · Brigham And Women'S Hospital · P01 · FY2019 · CA

Role of the bile acid activated receptors FXR and TGR5 in Total Parenteral Nutrition associated hepatic and gut disease

$142,224
Ajay K. Jain · Saint Louis University · K08 · FY2016 · DK

Preclinical dosing optimization: Dosing schedule, tissue

$141,786
Kanneboyina Nagaraju · Children'S Research Institute · U54 · FY2014 · HD

Additional bioanalytical, dose analysis and DSMB costs for PTI-125 development

$141,748
Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2017 · AG

Aging And The Pancreas

$141,638
Josephine Egan · National Institute On Aging · ZIA · FY2016 · AG

Glucagon-Like Peptide-1 (GLP-1) Signaling in the Olfactory System

$141,600
Nicolas Thiebaud · Florida State University · R03 · FY2016 · DC

Intravenous Protein Therapy for Myotonic Dystrophy Type 1

$141,092
Dustin Armstrong · Valerion Therapeutics, Llc · R21 · FY2009 · NS

Interactions of dietary polyphenols, gut microbiota and intestinal epithelium

$140,749
Diana Elizabeth Roopchand · Rutgers, The State Univ Of N.J. · K01 · FY2018 · AT

Interactions of dietary polyphenols, gut microbiota and intestinal epithelium

$140,749
Diana Elizabeth Roopchand · Rutgers, The State Univ Of N.J. · K01 · FY2016 · AT

Interactions of dietary polyphenols, gut microbiota and intestinal epithelium

$140,749
Diana Elizabeth Roopchand · Rutgers, The State Univ Of N.J. · K01 · FY2017 · AT

Translational Research for Retinal Degeneration Therapies

$140,375
Gustavo David Aguirre · University Of Pennsylvania · R01 · FY2009 · EY

Vector Core

$140,042
Julie Johnston · University Of Pennsylvania · P01 · FY2009 · HD

A novel therapeutic to ameliorate chronic pain and reduce opiate use

$139,986
Boris Tabakoff · Lohocla Research Corporation · UH3 · FY2024 · DA

A nanoparticle prognosticator of chemotherapy outcomes

$139,513
Russell M Lebovitz · Marval Biosciences, Inc. · R43 · FY2009 · CA

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

$139,267
Chee W Chia · National Institute On Aging · ZIA · FY2023 · AG

Preventing invasive prostate cancer

$138,214
Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2025 · CA

Preclinical dosing optimization: Dosing schedule, tissue

$137,866
Kanneboyina Nagaraju · Children'S Research Institute · U54 · FY2013 · HD

Regulation of Food Intake via the Glucagon-Like Peptide-1 Receptor

$137,836
Julio E Ayala · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK

Reduction of myocardial damage during acute ischemia

$137,792
Mark Talan · National Institute On Aging · ZIA · FY2009 · AG

Myocardial and Vascular Stiffness in Diabetics with Heart Failure and a Norman EF

$136,560
David Aguilar · Baylor College Of Medicine · K01 · FY2009 · HL

Myocardial and Vascular Stiffness in Diabetics with Heart Failure and a Norman EF

$136,560
David Aguilar · Baylor College Of Medicine · K01 · FY2010 · HL

Myocardial and Vascular Stiffness in Diabetics with Heart Failure and a Norman EF

$136,560
David Aguilar · Baylor College Of Medicine · K01 · FY2008 · HL

COCAINE THERAPEUTIC: PD2005 DOPAMINE TRANSPORT INHIBITOR

$136,520
Phase 2 Discovery, Inc. · R43 · FY2004 · DA